Pharosyn
AI agents for strategic intelligence in pharma.
Pharosyn is enabling pharmaceutical teams to transform competitive intelligence workflows with upscaled continuous data ingestion, automated filtering and tailored implications generation.
Founders
Stephen Cowley
CEO
Stephen pushed the limits of AI at Cambridge University and graduated in the top 5%. At the same time he built the first AI models at a neurotech startup that went on to get VC backed.
Joshua Hampson
CTO
Josh spent four years leading engineering teams from $2M to $12M revenue, building time-critical data platforms that inform decision-making at the biggest hedge funds. Before that he graduated top 5% in biochemistry at Cambridge University and built AI drug models at AstraZeneca.